Kumaraguru Raja
Stock Analyst at Brookline Capital Markets
(0.20)
# 4,410
Out of 4,564 analysts
205
Total ratings
31.4%
Success rate
-6.4%
Average return
Main Sectors:
Stocks Rated by Kumaraguru Raja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDSA Edesa Biotech | Initiated Coverage: Buy | $18 → $21 | $5.66 | +271.02% | 10 | Jun 29, 2026 | |
| ERNA Ernexa Therapeutics | Initiated Coverage: Buy | $30 | $3.99 | +651.88% | 1 | May 7, 2026 | |
| IRD Opus Genetics | Initiated Coverage: Buy | $10 → $8 | $2.92 | +173.97% | 4 | Dec 1, 2025 | |
| MDCX Medicus Pharma | Maintained: Buy | $12 → $20 | $0.3842 | +5,105.62% | 2 | Sep 24, 2025 | |
| NBP NovaBridge Biosciences | Maintained: Buy | $6 → $8 | $1.77 | +351.98% | 2 | Aug 28, 2025 | |
| FBRX Forte Biosciences | Maintained: Buy | $150 → $54 | $59.70 | -9.55% | 6 | Aug 15, 2025 | |
| INTS Intensity Therapeutics | Upgraded: Buy | $75 | $4.43 | +1,593.00% | 2 | Aug 12, 2025 | |
| ADIL Adial Pharmaceuticals | Maintained: Buy | $8 → $50 | $2.68 | n/a | 4 | Jun 26, 2025 | |
| HURA TuHURA Biosciences | Initiated Coverage: Buy | $9 | $2.15 | n/a | 1 | Jun 23, 2025 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $3 → $58 | $105.70 | n/a | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $18.28 | n/a | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $2.02 | n/a | 1 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $1.56 | n/a | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $5.46 | n/a | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $3.58 | n/a | 1 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $1.65 | n/a | 1 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.2 | $1.49 | n/a | 3 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.4981 | n/a | 1 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 → $5 | $1.26 | n/a | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $74 | $0.0001 | n/a | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $330 | $0.0001 | n/a | 3 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.96 | n/a | 9 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $2.31 | n/a | 20 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.32 | n/a | 9 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 | $5.79 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $7 | $0.4995 | n/a | 8 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.905 | n/a | 6 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.80 | n/a | 6 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.12 | n/a | 5 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $0.8751 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14.00 | $0.35 | n/a | 5 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $1.66 | n/a | 8 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $2 | $1.26 | n/a | 2 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $5.22 | n/a | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $0.0455 | n/a | 5 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $5.41 | n/a | 1 | Feb 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $0.0004 | n/a | 9 | Dec 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.47 | n/a | 3 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.04 | n/a | 2 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.27 | n/a | 3 | Dec 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $9.32 | n/a | 4 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.62 | n/a | 1 | Aug 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.06 | n/a | 2 | Aug 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.38 | n/a | 1 | May 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.48 | n/a | 2 | May 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $2.28 | n/a | 1 | May 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.459 | n/a | 1 | May 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $0.4 | $12.34 | n/a | 2 | Jun 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $537 → $480 | $651.91 | n/a | 4 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $130.86 | n/a | 1 | Apr 6, 2015 |
Edesa Biotech
Jun 29, 2026
Initiated Coverage: Buy
Price Target: $18 → $21
Current: $5.66
Upside: +271.02%
Ernexa Therapeutics
May 7, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $3.99
Upside: +651.88%
Opus Genetics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $10 → $8
Current: $2.92
Upside: +173.97%
Medicus Pharma
Sep 24, 2025
Maintained: Buy
Price Target: $12 → $20
Current: $0.3842
Upside: +5,105.62%
NovaBridge Biosciences
Aug 28, 2025
Maintained: Buy
Price Target: $6 → $8
Current: $1.77
Upside: +351.98%
Forte Biosciences
Aug 15, 2025
Maintained: Buy
Price Target: $150 → $54
Current: $59.70
Upside: -9.55%
Intensity Therapeutics
Aug 12, 2025
Upgraded: Buy
Price Target: $75
Current: $4.43
Upside: +1,593.00%
Adial Pharmaceuticals
Jun 26, 2025
Maintained: Buy
Price Target: $8 → $50
Current: $2.68
Upside: n/a
TuHURA Biosciences
Jun 23, 2025
Initiated Coverage: Buy
Price Target: $9
Current: $2.15
Upside: n/a
Monopar Therapeutics
May 13, 2025
Maintained: Buy
Price Target: $3 → $58
Current: $105.70
Upside: n/a
Dec 18, 2024
Initiated Coverage: Buy
Price Target: $9
Current: $18.28
Upside: n/a
Nov 20, 2024
Initiated Coverage: Buy
Price Target: $38
Current: $2.02
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $9
Current: $1.56
Upside: n/a
Jul 9, 2024
Initiated Coverage: Buy
Price Target: $80
Current: $5.46
Upside: n/a
Jun 6, 2024
Initiated Coverage: Buy
Price Target: $8
Current: $3.58
Upside: n/a
Jun 29, 2023
Initiated Coverage: Buy
Price Target: $15
Current: $1.65
Upside: n/a
May 30, 2023
Downgraded: Hold
Price Target: $2 → $1.2
Current: $1.49
Upside: n/a
Mar 3, 2023
Initiated Coverage: Buy
Price Target: $9
Current: $0.4981
Upside: n/a
Jan 5, 2023
Initiated Coverage: Buy
Price Target: $6 → $5
Current: $1.26
Upside: n/a
Nov 29, 2022
Maintained: Buy
Price Target: $80 → $74
Current: $0.0001
Upside: n/a
Oct 17, 2022
Maintained: Buy
Price Target: $12 → $330
Current: $0.0001
Upside: n/a
Aug 15, 2022
Maintained: Buy
Price Target: n/a
Current: $3.96
Upside: n/a
Aug 11, 2022
Maintained: Buy
Price Target: $31
Current: $2.31
Upside: n/a
Aug 11, 2022
Reiterated: Buy
Price Target: $6
Current: $1.32
Upside: n/a
Aug 10, 2022
Reiterated: Buy
Price Target: $74
Current: $5.79
Upside: n/a
Aug 8, 2022
Rated: Buy
Price Target: $10 → $7
Current: $0.4995
Upside: n/a
Aug 1, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.905
Upside: n/a
Jun 2, 2022
Reiterated: Buy
Price Target: $12
Current: $3.80
Upside: n/a
May 24, 2022
Maintained: Buy
Price Target: n/a
Current: $2.12
Upside: n/a
May 13, 2022
Reiterated: Buy
Price Target: $22
Current: $0.8751
Upside: n/a
May 2, 2022
Reiterated: Buy
Price Target: $14.00
Current: $0.35
Upside: n/a
Apr 5, 2022
Reiterated: Buy
Price Target: $45
Current: $1.66
Upside: n/a
Sep 28, 2021
Maintained: Buy
Price Target: $14 → $2
Current: $1.26
Upside: n/a
Aug 17, 2021
Maintained: Buy
Price Target: $7
Current: $5.22
Upside: n/a
Mar 23, 2021
Reiterated: Buy
Price Target: $12 → $6
Current: $0.0455
Upside: n/a
Feb 2, 2021
Initiated Coverage: Buy
Price Target: $10
Current: $5.41
Upside: n/a
Dec 16, 2020
Reiterated: Buy
Price Target: $35
Current: $0.0004
Upside: n/a
Feb 20, 2020
Reiterated: Buy
Price Target: $6
Current: $2.47
Upside: n/a
Mar 28, 2019
Rated: Hold
Price Target: n/a
Current: $4.04
Upside: n/a
Dec 24, 2018
Rated: Hold
Price Target: n/a
Current: $1.27
Upside: n/a
Oct 22, 2018
Maintained: Buy
Price Target: $25
Current: $9.32
Upside: n/a
Aug 30, 2018
Maintained: Hold
Price Target: n/a
Current: $10.62
Upside: n/a
Aug 4, 2017
Reiterated: Buy
Price Target: n/a
Current: $2.06
Upside: n/a
May 26, 2017
Reiterated: Buy
Price Target: n/a
Current: $9.38
Upside: n/a
May 22, 2017
Reiterated: Buy
Price Target: n/a
Current: $2.48
Upside: n/a
May 16, 2017
Reiterated: Hold
Price Target: $10
Current: $2.28
Upside: n/a
May 10, 2017
Reiterated: Buy
Price Target: n/a
Current: $0.459
Upside: n/a
Jun 29, 2016
Downgraded: Hold
Price Target: $3.5 → $0.4
Current: $12.34
Upside: n/a
Feb 25, 2016
Initiated Coverage: Buy
Price Target: $537 → $480
Current: $651.91
Upside: n/a
Apr 6, 2015
Reiterated: Buy
Price Target: $120
Current: $130.86
Upside: n/a